Welcome to the winter edition of Oncology and Hematology Review (US). This edition features timely and concise review articles examining a wide variety of important topics. The areas covered range from prostate cancer and gallbladder cancer to head and neck cancer and lung cancer. There are insightful discussions of bevacizumab in epithelial ovarian cancer and adjuvant therapy in high-risk melanoma. This edition concludes with articles on geriatric oncology, acute leukemia, anaplastic lymphoma kinase and chemotherapy-induced nausea and vomiting, all providing a worthy focus for our attention. Please peruse and enjoy the expert content and we welcome your feedback.